New pill could ease back pain for ankylosing spondylitis patients
NCT ID NCT05861102
First seen Jan 11, 2026 · Last updated May 09, 2026 · Updated 14 times
Summary
This study tests a new drug called jaktinib for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 265 adults will receive either jaktinib or a placebo to see if the drug improves pain and function after 16 weeks. The goal is to find a new treatment option for this chronic condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RenJi Hospital
Shanghai, Shanghai Municipality, 200001, China
Conditions
Explore the condition pages connected to this study.